These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8480773)

  • 1. Upjohn pharmacist reimbursement programs halted by FDA.
    Am J Hosp Pharm; 1993 Feb; 50(2):200, 205. PubMed ID: 8480773
    [No Abstract]   [Full Text] [Related]  

  • 2. Program reimburses pharmacists who counsel patients on glyburide product.
    Am J Hosp Pharm; 1992 Nov; 49(11):2645-6. PubMed ID: 1471621
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA action spurs change in groups' drug programs.
    Perry PA
    Hosp Mater Manage; 1989 Nov; 14(11):1, 13-4. PubMed ID: 10295911
    [No Abstract]   [Full Text] [Related]  

  • 4. Program for reimbursement of cognitive services is misleading.
    Micklewright M; Orr EJ; Ford JD
    Am J Hosp Pharm; 1993 Feb; 50(2):258, 261. PubMed ID: 8329054
    [No Abstract]   [Full Text] [Related]  

  • 5. Bolar agrees to guilty plea in generic drug probe.
    Wagner M
    Mod Healthc; 1991 Mar; 21(9):17. PubMed ID: 10109180
    [No Abstract]   [Full Text] [Related]  

  • 6. Eliminating neglected diseases: impact of published paper.
    Brownback S
    Health Aff (Millwood); 2007; 26(5):1509. PubMed ID: 17848471
    [No Abstract]   [Full Text] [Related]  

  • 7. Lawsuits anticipated on generic biologicals front.
    Fox JL
    Nat Biotechnol; 2003 Jul; 21(7):721-2. PubMed ID: 12833078
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA takes action against firms in scandal over generic products.
    Pollner F
    Med World News; 1989 Sep; 30(17):14-5. PubMed ID: 10294736
    [No Abstract]   [Full Text] [Related]  

  • 9. Hearing shines spotlight on biosimilar controversies.
    Mullard A
    Nat Rev Drug Discov; 2010 Dec; 9(12):905-6. PubMed ID: 21119720
    [No Abstract]   [Full Text] [Related]  

  • 10. Rho Chi Lecture. Ideals and innovation: drugs, generics, the FDA, and the pharmacist.
    Benet LZ
    DICP; 1991 Apr; 25(4):427-30. PubMed ID: 1926916
    [No Abstract]   [Full Text] [Related]  

  • 11. Should the FDA regulate pharmacoeconomic studies?
    Robinson M
    HMO; 1996; 37(1):71-5. PubMed ID: 10159353
    [No Abstract]   [Full Text] [Related]  

  • 12. In U.S., biosimilars still await FDA decision.
    Finkelstein JB
    J Natl Cancer Inst; 2006 Apr; 98(7):435. PubMed ID: 16595775
    [No Abstract]   [Full Text] [Related]  

  • 13. Coupon programs curb antihistamine utilization.
    Berberabe T
    Manag Care; 2003 Aug; 12(8):28-9. PubMed ID: 12966848
    [No Abstract]   [Full Text] [Related]  

  • 14. Perspectives. FDA scandal: white hats, black hats, gray areas.
    Wiener JO
    Faulkner Grays Med Health; 1989 Dec; 43(48):suppl 6 p.. PubMed ID: 10296081
    [No Abstract]   [Full Text] [Related]  

  • 15. The pharmacist and the doctor.
    Mason R
    Nebr Med J; 1973 Jan; 58(1):17-20. PubMed ID: 4682786
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA considers effects of managed care marketplace on drug promotional practices.
    Wechsler J
    Formulary; 1995 Dec; 30(12):840-1. PubMed ID: 10153083
    [No Abstract]   [Full Text] [Related]  

  • 17. Members of new FDA board tied to industry.
    Finkelstein JB
    J Natl Cancer Inst; 2008 Mar; 100(5):296-7. PubMed ID: 18314467
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA to steer nanotech.
    Fox JL
    Nat Biotechnol; 2008 Oct; 26(10):1060. PubMed ID: 18846060
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA tightens rules on advertising.
    Josefson D
    BMJ; 1997 Aug; 315(7106):447. PubMed ID: 9284658
    [No Abstract]   [Full Text] [Related]  

  • 20. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality?
    Marsh DA; Hoar ME
    Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.